quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:00:10·314d
INSIDERFiling
Agrify Corporation logo

Director Varier Krishnan sold $120,140 worth of shares (5,000 units at $24.03), was granted 5,000 shares and converted options into 5,000 shares (SEC Form 4)

AGFY· Agrify Corporation
Consumer Staples
Original source

Companies

  • AGFY
    Agrify Corporation
    Consumer Staples

Recent analyst ratings

  • Mar 23UpdateCraig Hallum-
  • Nov 1UpdateAlliance Global Partners$32.00
  • Aug 13UpdateRoth Capital$31.00
  • Jul 23UpdateCraig Hallum$25.00

Related

  • INSIDER232d
    Interim CEO Kovler Benjamin bought $36,700 worth of shares (1,000 units at $36.70), increasing direct ownership by 6% to 17,000 units (SEC Form 4)
  • INSIDER232d
    SEC Form 4 filed by Large owner Rslgh, Llc
  • INSIDER233d
    Interim CEO Kovler Benjamin bought $46,700 worth of shares (1,000 units at $46.70), increasing direct ownership by 7% to 16,000 units (SEC Form 4)
  • INSIDER233d
    Director Holtzman Max sold $213,560 worth of shares (5,000 units at $42.71), decreasing direct ownership by 50% to 5,000 units (SEC Form 4)
  • INSIDER239d
    SEC Form 4 filed by Large owner Rslgh, Llc
  • SEC239d
    Agrify Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits
  • PR239d
    Agrify Corporation to Change Its Name to RYTHM, Inc. Following Brand Portfolio Acquisition
  • PR239d
    Green Thumb Industries Announces Brand Transactions with Agrify
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022